Extension to THRIVE trial (PAF 10-0383 project code R2380)

Project Details


Women vulnerable in pregnancy are likely to be more anxious, depressed and produce higher levels of stress-related hormones htan women who are not. Evidence is growing that depression, stress and anxiety in pregnant women can: 1. have adverse consequences that permanently affect the baby's response to stress and 2. disrupt the mother's ability to be sensitive to her baby. Women identified as vulnerable in pregnancy will be recruited to a 3-armed, randomised trial to compare the cost-effectiveness of 2 interventions in improving both mother-child interaction and maternal mental health: Enhanced Triple P for Baby and Mellow Bumps.
Effective start/end date1/02/1831/07/19


  • National Institute for Health Research: £556,414.50


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.